An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

National Agricultural Library
U.S. Department of Agriculture
  1. Home
  2. Human Nutrition and Food Safety
  3. Research Publications (Food Safety)

Research Publications (Food Safety)

This page tracks research articles published in national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. Research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies (requires login) and FDA Grant Funding Agencies (requires login) are also tracked in Scopus.

Displaying 351 - 375 of 2090

  1. Isolation and characterization of a novel strain of duck aviadenovirus B from Muscovy ducklings with acute hepatitis in China

    • Transboundary and Emerging Diseases

    • Transboundary and Emerging Diseases, EarlyView.

      • Viruses
      • Hepatitis

  2. First report of equine parvovirus‐hepatitis and equine hepacivirus coinfection in horses in Korea

    • Transboundary and Emerging Diseases

    • Transboundary and Emerging Diseases, EarlyView.

      • Viruses
      • Hepatitis

  3. Serological and molecular survey of hepatitis E virus in cats and dogs in Spain

    • Transboundary and Emerging Diseases

    • Transboundary and Emerging Diseases, EarlyView.

      • Viruses
      • Hepatitis

  4. Zoonotic transmission of hepatitis E virus in a pig farmer from Argentina: A case report

    • Zoonoses and Public Health

    • Zoonoses and Public Health, EarlyView.

      • Viruses
      • Hepatitis

  5. A review of epidemic investigation on cold‐chain food‐mediated SARS‐CoV‐2 transmission and food safety consideration during COVID‐19 pandemic

    • Journal of Food Safety

    • Journal of Food Safety, Volume 41, Issue 6, December 2021.

      • Viruses
      • COVID-19

  6. What Can the Effects of COVID Reveal About Lingering Obstacles to Retention for Women in STEM?

    • Fisheries

    • Fisheries, Accepted Article.

      • Viruses
      • COVID-19

  7. Evaluation of hydrogen peroxide efficacy against AZD1222 chimpanzee adenovirus strain in the recombinant COVID‐19 vaccine for application in cleaning validation in a pharmaceutical manufacturing industry

    • Letters in Applied Microbiology

    • Letters in Applied Microbiology, EarlyView.

      • Viruses
      • COVID-19

  8. Tea crude extracts effectively inactivate severe acute respiratory syndrome coronavirus 2

    • Letters in Applied Microbiology

    • Letters in Applied Microbiology, Volume 74, Issue 1, Page 2-7, January 2022.

      • Viruses
      • COVID-19

  9. Host‐modifying drugs against COVID‐19: some successes, but not yet the breakthrough

    • Environmental Microbiology

    • Environmental Microbiology, EarlyView.

      • Viruses
      • COVID-19

  10. Clinical trials with antiviral drugs against COVID‐19: some progress and many shattered hopes

    • Environmental Microbiology

    • Environmental Microbiology, Volume 23, Issue 11, Page 6364-6376, November 2021.

      • Viruses
      • COVID-19

  11. Widespread Contamination of SARS‐CoV‐2 on Highly Touched Surfaces in Brazil During the Second Wave of the COVID‐19 Pandemic

    • Environmental Microbiology

    • Environmental Microbiology, Accepted Article.

      • Viruses
      • COVID-19

  12. The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID‐19 vaccine

    • Allergy

    • Allergy, EarlyView.

      • Viruses
      • COVID-19

  13. The form of PEG matters: PEG conjugated with lipids and not PEG alone could be the specific form involved in allergic reactions to COVID‐19 vaccines

    • Allergy

    • Allergy, Accepted Article.

      • Viruses
      • COVID-19

  14. COVID‐19 vaccines tolerated in patients with paclitaxel and docetaxel allergy

    • Allergy

    • Allergy, EarlyView.

      • Viruses
      • COVID-19

  15. Childhood BCG vaccination seems to selectively protect adult males from COVID‐19 infection

    • Allergy

    • Allergy, EarlyView.

      • Viruses
      • COVID-19

  16. Mast cell activation is associated with post‐acute COVID‐19 syndrome

    • Allergy

    • Allergy, EarlyView.

      • Viruses
      • COVID-19

  17. Experience with polyethylene glycol allergy‐guided risk management for COVID‐19 vaccine anaphylaxis

    • Allergy

    • Allergy, EarlyView.

      • Viruses
      • COVID-19

  18. Regulatory concepts to guide and promote the accelerated but safe clinical development and licensure of COVID‐19 vaccines in Europe

    • Allergy

    • Allergy, Volume 77, Issue 1, Page 72-82, January 2022.

      • Viruses
      • COVID-19

  19. COVID‐19 vaccines—The way forward

    • Allergy

    • Allergy, Volume 77, Issue 1, Page 15-16, January 2022.

      • Viruses
      • COVID-19

  20. COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies

    • Allergy

    • Allergy, Volume 77, Issue 1, Page 304-307, January 2022.

      • Viruses
      • COVID-19

  21. Antiviral response in vernal keratoconjunctivitis may be protective against COVID‐19

    • Allergy

    • Allergy, Volume 77, Issue 1, Page 298-300, January 2022.

      • Viruses
      • COVID-19

  22. Adding the variable of environmental complexity into the COVID‐19 pandemic equation

    • Allergy

    • Allergy, Volume 77, Issue 1, Page 331-333, January 2022.

      • Viruses
      • COVID-19

  23. Successful administration of second dose of BNT162b2 COVID‐19 vaccine in two patients with potential anaphylaxis to first dose

    • Allergy

    • Allergy, Volume 77, Issue 1, Page 337-338, January 2022.

      • Viruses
      • COVID-19

  24. Asthma phenotypes, associated comorbidities, and long‐term symptoms in COVID‐19

    • Allergy

    • Allergy, Volume 77, Issue 1, Page 173-185, January 2022.

      • Viruses
      • COVID-19

  25. Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS‐CoV‐2 infection and long COVID

    • Allergy

    • Allergy, Volume 77, Issue 1, Page 118-129, January 2022.

      • Viruses
      • COVID-19